This clinical trial is focused on patients who have undergone major emergency abdominal surgery. The study is investigating the effects of two different approaches to providing additional nutrition through the veins, known as supplementary parenteral nutrition. The two treatments being compared are called SmofKabiven and SmofKabiven Perifer, which are both emulsions for infusion. These treatments contain a mix of essential nutrients, including amino acids, oils, and minerals, to support recovery after surgery.
The purpose of the study is to compare the impact of starting supplementary parenteral nutrition early versus postponing it on the risk of infections that patients might acquire in the hospital after their surgery. Participants in the study will receive either the early or postponed nutrition treatment, or a placebo, and their progress will be monitored over time. The study aims to see if the timing of the nutrition affects the rate of infections and other complications during the hospital stay.
Throughout the study, researchers will observe various outcomes, such as the rate of complications, the length of hospital stay, and mortality rates at 30, 90, and 180 days after surgery. They will also track the amount and type of energy and protein intake during the hospital stay. This information will help determine the best approach to providing nutrition to patients recovering from major emergency abdominal surgery.
Denmark 
